Business
Colombian Government Provides Final Commercial Guidelines Related to the Export of Dried Flower
Colombian Government Provides Final Commercial Guidelines Related to the Export of Dried ...
About this update from Pharmacielo Ltd.
[{"type":"text","content":"\n \n \n \n Colombian Government Provides Final Commercial Guidelines Related to the Export of Dried Flower\n \n \n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n \n \n \n \n \n \n Canada NewsWire\n \n \n \n \n \n \n Builds on the passing of Regulation 227 in February, which implemented legal provisions to enable dried flower export and access to additional opportunities for CBD-based products.\n \n \n \n \n PharmaCielo expects to begin exporting dried flower in the second quarter of 2022, with volumes growing through the remainder of the year.\n \n \n \n \n \n \n TORONTO\n \n and RIONEGRO,\n \n Colombia\n \n \n ,\n \n \n April 4, 2022\n \n \n /CNW/ - PharmaCielo Ltd. (\"PharmaCielo\" or the \"Company\") (TSXV: PCLO) (OTCQX: PCLOF), the Canadian parent of Colombia's premier cultivator and producer of dried flower and medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S. (\"Holdings\"), today welcomed the Colombian Government's announcement of final commercial guidelines that will regulate the export of dried flower from\n \n Colombia\n \n , as well as the exportation of other cannabis based products. This announcement follows the\n \n Government's passing of Regulation 227\n \n on\n \n February 22, 2022\n \n , which was designed to make the country's cannabis industry more competitive on a global scale.\n \n \n Management Commentary\n \n \n \n \n Bill Petron\n \n , CEO of PharmaCielo\n \n , commented, \"The Colombian Government's release of final commercial guidelines further solidifies its commitment to turning the Colombian cannabis industry into a global leader. PharmaCielo expects to begin shipping dried flower in Q2 of this year, with volumes growing through the fourth quarter and 2023 and is well-positioned to capture market share in import-dependent markets such as\n \n Germany\n \n ,\n \n Israel\n \n and\n \n Australia\n \n . These markets are currently being supplied by relatively high-cost flower from producers in countries like\n \n Canada\n \n . PharmaCielo's structural cost advantage, sophisticated approach to genetics and processing, and...